TG Therapeutics | TGTX - Ordinary Share Capital


TG Therapeutics reported $155.21M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Amgen USD 538M 300K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Arrowhead Research USD 135.7M 2.44M Sep/2025
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Dynavax Technologies USD 117.23M 117.11M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
J&J USD 2.41B 584K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025